All Comments by Dave Morgan
- ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models.
- Smuggling Antibodies to BACE Across the Blood-Brain Barrier
- Neuroprotective natural antibodies to assemblies of amyloidogenic peptides decrease with normal aging and advancing Alzheimer's disease.
- Piping in Passive Immunization Spares Blood Vessels
- Alzheimer disease macrophages shuttle amyloid-beta from neurons to vessels, contributing to amyloid angiopathy.
- Immunotherapy reduces vascular amyloid-beta in PDAPP mice.
- Complement: AD Friend or Foe? New Work Tips Balance to Former
- AD Immunotherapy: Toward Prevention, DNA-based Vaccines?
- A two-year study with fibrillar beta-amyloid (Abeta) immunization in aged canines: effects on cognitive function and brain Abeta.
- Incidence and prognosis of transient neurological attacks.
- Virosome-based active immunization targets soluble amyloid species rather than plaques in a transgenic mouse model of Alzheimer's disease.
- Exacerbation of cerebral amyloid angiopathy-associated microhemorrhage in amyloid precursor protein transgenic mice by immunotherapy is dependent on antibody recognition of deposited forms of amyloid beta.
- San Diego: Treating Forgetfulness—Triple Transgenics Provoke
- Tackling Alzheimer’s from the Outside In
- Primate Model Promising for Studying Aβ Vaccine